|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | An alter-nate synthetich to goucerotin显示文摘 | Tetsuo Wolfgang Winterfeldt Yuzuru Sanemitsu | 1975 | Tetrahedr Lett1975，41，： | 1 |
| 2 | Asymptomatic carriers of hydatidosis : epidemiology, diagnosis and treatment 显示文摘 | Larrieu Edmundo Frider | 2000 | Pan American Journal of Public Health2000，8，4： | 1 |
| 3 | Basic minimum needs, quality of life and selected correlates : Explorations in villages in northern India显示文摘 | BRINKERHOFF M B FREDELL K A FRIDERES J S | 1997 | Social IndicatorsResearch1997，42，： | 1 |
| 4 | Reversal of advanced fi- brosis after long-term ursedeoxycholic acid therapy in a patient with residual expression of MDR3 显示文摘 | Frider B Castillo A Gordo-Gilart R | 2015 | Ann Hepatol2015，14，5： | 1 |
| 5 | Discussion on randomized comparison of long term losartan versus propranolol in lowering portal pressure in cirrhosis显示文摘 | Castano G Viudez P Frider B | 2002 | Gastroenterology2002，122，6： | 1 |
| 6 | Reversal of ad- vanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3显示文摘 | Frider B Castillo A Gordo-Gilart R | 2015 | Ann Hepatol2015，14，5： | 1 |
| 7 | Long-term outcome of asymptomatic liver hydatidosis显示文摘 | Bernardo Frider Edmundo Larrieu Martín Odriozola | 1999 | Journal of Hepatology1999，，2： | 1 |
| 8 | Development of porphyria cutanea tarda in a chronic hepatitis C patient with indetectable viremia under treatment with peg-interferon plus ribavirin 显示文摘 | Frider B Buonsante ME Tiscornia J | 2006 | Acta Gastroenterol Latinoam2006，36，： | 1 |
| 9 | Discussion on randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis显示文摘 | Castano G Viudez P Frider B | 2002 | Gastroenterology2002，122，5： | 1 |
| 10 | Kasabach-Merrit syndrome and adult hepatic epithelioid hemangioendothelioma an unusual association显示文摘 | Frider B Bruno A Selser J | 2005 | J Hepatol2005，42，2： | 1 |
| 11 | Epidemiologieal surveillance of human hydatidosis by means of ultrasonography: its contribution to the evaluation of control programs显示文摘 | Frider B Moguilensky J Salvitti JC | 2001 | Acta Trop2001，79，3： | 1 |
| 12 | Epidemiological surveillance of human hydatidosis by means of ultrasonography: its contribution to the evaluation of control programs显示文摘 | Frider B Moguilensy J Salvitti JC | 2001 | Acta Trop2001，79，： | 1 |
| 13 | Identification of 2 novel isolates of hepatitis E virus in Argentina显示文摘 | Schlauder GG Frider B Sookoian S | 2000 | J Infect Dis2000，182，： | 1 |
| 14 | Opioid and nonopioid compo- nents independently contribute to the mechanism of action of tramadol an atypical opioid analgeisic 显示文摘 | Raffa RR Frider Iches | 1992 | Phamcol ELP T- her1992，260，： | 1 |
| 15 | Discussion on randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis显示文摘 | CASTA:IO G VIUDEZ P FRIDER B | 2002 | Gastroenterology2002，122，5： | 1 |
| 16 | Discussion on randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis显示文摘 | Castano G Viudez P Frider B | 2002 | Gastroenterology2002，122，5： | 1 |
| 17 | Adsorption measurement of water/ethanol mixtures on activated carbon fiber显示文摘 | Frider Dreisbach Hans Wilhelm Losch Kazuyuld Nakai | 2001 | Chem Eng Technol2001，24，： | 1 |
| 18 | Detection of hepatitis G virus RNA in patients with acute non A-E hepatitis显示文摘 | Frider B,Sookoian S,Gastano G, | 1998 | J Viral Hepat1998，5161，： | 1 |
| 19 | Kasabach-Merrit syndrome and adult hepatic epithelioid hemangioendothelioma an unusual association显示文摘 | Frider B Bruno A Selser J | 2005 | J Hepatol2005，42，： | 1 |
| 20 | Treatment of liver hydatidosis:How to treat an asymptomatic carrier?显示文摘Liver hydatidosis is the most common clinical presentation of cystic echinococcosis(CE).Ultrasonographic mass surveys have demonstrated the true prevalence,including the asymptomatic characteristic of the majority of cases,providing new insight into the natural history of the disease.This raises the question of whether to treat or not to treat these patients,due to the high and unsuspected prevalence of CE.The high rate of liver/lung frequencies of cyst localization,the autopsy findings,and the involution of cysts demonstrated in long time follow-up of asymptomatic carriers contribute to this discussion.The decision to treat an asymptomatic patient by surgery,albendazole,or puncture aspiration injection and reaspiration or to wait and watch,is based on conflicting reports in the literature,the lack of complications in untreated patients over time,and the spontaneous disappearance and involution of cysts.All these points contribute to difficulties of individual clinical decisions.The patients should be informed of the reasons and the risks of watchful/waiting without treatment,the possibility of complications,and the risks of the other options.As more information on the natural history of liver hydatidosis is acquired,selection of the best treatment will be come easier.Without this knowledge it would be very difficult to establish definitive rules of treatment.At present,it is possible to manage these patients over time and to wait for the best moment for treatment.Followup studies must be conducted to achieve this objective. | Bernardo Frider Edmundo Larrieu | 2010 | World Journal of Gastroenterology2010，16，33： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员